Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03249571 · ClinicalTrials.gov registry record · NA
Flavonoids, Exercise, Gut-Derived Phenolics
A NA study, sponsored by Appalachian State University.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT03249571 is a NA study that has completed, run by Appalachian State University. The registered enrollment target is 100 participants.
The verdict
NCT03249571, a NA study, has completed, sponsored by Appalachian State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
PURPOSE: 1. PRIMARY: Using a randomized, parallel group design, this investigation will determine if the combination of 2-weeks polyphenol supplementation (using the Reoxcyn flavonoid supplement in capsule form) and one acute 45-minute brisk walking bout enhances the translocation of gut-derived phenolics into the circulation. A comparator group of runners (N=20) ingesting the flavonoid supplement for two weeks will be included (2.5 h run, 70% VO2max). 2. SECONDARY: Data from this study will determine if 2-weeks supplementation of the Reoxcyn flavonoid supplement is a sufficient time period to increase circulating levels of gut-derived phenolics, extending data collected from the previous 12-week community trial. HYPOTHESIS: We hypothesize that an acute 45-minute brisk walking exercise bout (60% VO2max) following 2 weeks of increased polyphenol intake will be a sufficient exercise stimulus to increase gut permeability and the movement of gut-derived phenolics into circulation. If this hypothesis is confirmed, these data would have broad public health appeal, demonstrating that the combination of brisk walking and increased polyphenol intake augments circulating levels of health-restoring small phenolic molecules derived from bacterial breakdown in the colon.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Flavonoid supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-06-05 |
| Est. Completion | 2017-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03249571
The ClinicalTrials.gov registry entry for NCT03249571 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Appalachian State University, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03249571 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03249571 about?
NCT03249571 is a clinical study titled "Flavonoids, Exercise, Gut-Derived Phenolics". PURPOSE: 1. PRIMARY: Using a randomized, parallel group design, this investigation will determine if the combination of 2-weeks polyphenol supplementation (using the Reoxcyn flavonoid supplement in capsule form) and one acute 45-minute brisk walking bout enhances the translocation of gut-derived ph...
What is the current status of trial NCT03249571?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2017-06-05. Estimated completion is 2017-08-30.
What interventions are being tested in trial NCT03249571?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Flavonoid supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03249571?
This trial is sponsored by Appalachian State University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.